Unknown

Dataset Information

0

Promotion of diet-induced obesity and metabolic syndromes by BID is associated with gut microbiota.


ABSTRACT: A growing body of evidence has indicated an expanding functional network of B-cell lymphoma 2 (BCL-2) family proteins beyond regulation of cell death and survival. Here, we examined the role and mechanisms of BH3 interacting-domain death agonist (BID), a pro-death BCL-2 family member, in the development of diet-induced metabolic dysfunction. Mice deficient in bid (bid-/- ) were resistant to high-fat diet (HFD)-induced obesity, hepatic steatosis, and dyslipidemia with an increased insulin sensitivity. Indirect calorimetry analysis indicated that bid deficiency increased metabolic rate and decreased respiratory exchange ratio, suggesting a larger contribution of lipids to overall energy expenditure. While expression of several genes related to lipid accumulation was only increased in wild-type livers, metabolomics analysis revealed a consistent reduction in fatty acids but an increase in certain sugars and Krebs cycle intermediates in bid-/- livers. Gut microbiota (GM) analysis indicated that HFD induced gut dysbiosis with differential patterns in wild-type and in bid-/- mice. Notably, abrogation of GM by antibiotics during HFD feeding eliminated the beneficial effects against obesity and hepatic steatosis conferred by the bid deficiency. Conclusion: These results indicate that the protective role of bid-deficiency against diet-induced metabolic dysfunction interacts with the function of GM.

SUBMITTER: Yan S 

PROVIDER: S-EPMC9701492 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Promotion of diet-induced obesity and metabolic syndromes by BID is associated with gut microbiota.

Yan Shengmin S   Zhou Jun J   Zhang Hao H   Lin Zhen Z   Khambu Bilon B   Liu Gang G   Ma Michelle M   Chen Xiaoyun X   Chalasani Naga N   Yin Xiao-Ming XM  

Hepatology communications 20221115 12


A growing body of evidence has indicated an expanding functional network of B-cell lymphoma 2 (BCL-2) family proteins beyond regulation of cell death and survival. Here, we examined the role and mechanisms of BH3 interacting-domain death agonist (BID), a pro-death BCL-2 family member, in the development of diet-induced metabolic dysfunction. Mice deficient in bid (bid<sup>-/-</sup> ) were resistant to high-fat diet (HFD)-induced obesity, hepatic steatosis, and dyslipidemia with an increased insu  ...[more]

Similar Datasets

| S-EPMC4808856 | biostudies-literature
| S-EPMC4436290 | biostudies-literature
| S-EPMC10828666 | biostudies-literature
| S-EPMC10574165 | biostudies-literature
| S-EPMC5123202 | biostudies-literature
| S-EPMC2928532 | biostudies-literature
| S-EPMC10931208 | biostudies-literature
| S-EPMC7230861 | biostudies-literature
| S-EPMC4935139 | biostudies-literature
| S-EPMC8398128 | biostudies-literature